Ascentage Pharma Group International Adr (AAPG)

Apr 27, 2025

Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio? - Benzinga

Apr 27, 2025

Apr 17, 2025

Ascentage Pharma Files Annual Report, Announces Shareholder Meeting By Investing.com - Investing.com South Africa

Apr 17, 2025

Apr 17, 2025

Ascentage Pharma Files Annual Report, Announces Shareholder Meeting - Investing.com

Apr 17, 2025

Mar 27, 2025

JPMorgan sets Ascentage Pharma stock to Overweight, $27 target - Investing.com

Mar 27, 2025

Mar 14, 2025

Takeda Pharmaceutical Company (TKPYY) Stock: Strategic Focus on Oncology and Growth Opportunities - Value the Markets

Mar 14, 2025

Mar 12, 2025

Ascentage Pharma to Announce 2024 Financial Results and Corporate Update - TipRanks

Mar 12, 2025

Jan 27, 2025

Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World - Dealbreaker

Jan 27, 2025

Jan 24, 2025

Ascentage Pharma IPO opens flat - Investing.com

Jan 24, 2025

Jan 24, 2025

Ascentage Pharma shares slide ahead of ADS debut on Nasdaq - Investing.com

Jan 24, 2025

Jan 23, 2025

Ascentage prices first biotech IPO of 2025, raising $126M - BioPharma Dive

Jan 23, 2025

Jan 22, 2025

Ascentage Pharma sets terms for $149 million US IPO - The Pharma Letter

Jan 22, 2025

Dec 30, 2024

Takeda-backed Ascentage Pharma files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha

Dec 30, 2024

Jun 24, 2024

Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares - PR Newswire

Jun 24, 2024

Jun 14, 2024

Takeda, Ascentage Pharma Sign Option Agreement - Contract Pharma

Jun 14, 2024

Nov 06, 2019

Capital Markets - Wilson Sonsini

Nov 06, 2019

Oct 13, 2012

Morningstar | Empowering Investor Success - Morningstar

Oct 13, 2012

Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN Logo

Jul 27, 2011